ANNX Competitors & Alternatives

Compare Annexon Inc with similar stocks in the same industry

Biotechnology

ANNX

Main Stock
$3.49
-2.38%
Tradestie Score
42
Market Cap
$332.96M
Analyst Upside
+387.8%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 2/10 Drug Discovery Biotech Drug Design
Competitive Moat: None
Core Technology Stack: classical complement inhibition, monoclonal antibodies
Major Customers 2
clinical research sites future patients with GA or autoimmune disease
Critical Suppliers 2
CROs biologic CMOs
Direct Ecosystem Rivals 3

Top Competitors

215 stocks in Biotechnology
Company Price Market Cap P/E Score Action
IOVA Iovance Biotherapeutics, Inc. Common Stock
$7.44
-1.46%
$799.70M - 62 Compare
KURA Kura Oncology, Inc.
$7.46
+5.22%
$798.53M - 69 Compare
VIR Vir Biotechnology, Inc. Common Stock
$9.25
-3.44%
$791.82M - 48 Compare
OLMA Olema Pharmaceuticals, Inc. Common Stock
$7.15
-2.85%
$757.72M - 44 Compare
AVBP ArriVent BioPharma, Inc. Common Stock
$10.72
-7.27%
$748.90M - 40 Compare
TBPH Theravance Biopharma, Inc.
$17.03
$726.21M 16.4 51 Compare
NRIX Nurix Therapeutics, Inc. Common stock
$14.24
-3.33%
$718.62M 6.4 50 Compare
TYRA Tyra Biosciences, Inc. Common Stock
$19.62
-0.63%
$715.25M - 35 Compare
DAWN Day One Biopharmaceuticals, Inc. Common Stock
$21.53
+0.19%
$704.73M - 51 Compare
PVLA Palvella Therapeutics, Inc. Common Stock
$142.94
-1.15%
$699.30M - 41 Compare

Data updated: Nov 17, 2026 | Industry: Biotechnology (SIC 2834)

215 stocks in this industry